Biogen Inc. (0R1B.L)
USD 122.29
(-2.27%)
USD 122.29
(-2.27%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 26.84 Billion USD | 9.33% |
| 2022 | 24.55 Billion USD | 2.83% |
| 2021 | 23.87 Billion USD | -3.01% |
| 2020 | 24.61 Billion USD | -9.6% |
| 2019 | 27.23 Billion USD | 7.69% |
| 2018 | 25.28 Billion USD | 6.92% |
| 2017 | 23.65 Billion USD | 3.39% |
| 2016 | 22.87 Billion USD | 17.29% |
| 2015 | 19.5 Billion USD | 36.24% |
| 2014 | 14.31 Billion USD | 20.68% |
| 2013 | 11.86 Billion USD | 17.11% |
| 2012 | 10.13 Billion USD | 11.94% |
| 2011 | 9.04 Billion USD | 11.83% |
| 2010 | 8.09 Billion USD | -5.37% |
| 2009 | 8.55 Billion USD | 0.86% |
| 2008 | 8.47 Billion USD | -1.74% |
| 2007 | 8.62 Billion USD | 0.89% |
| 2006 | 8.55 Billion USD | 2.22% |
| 2005 | 8.36 Billion USD | -8.72% |
| 2004 | 9.16 Billion USD | -3.56% |
| 2003 | 9.5 Billion USD | 373.54% |
| 2002 | 2 Billion USD | 16.61% |
| 2001 | 1.72 Billion USD | 20.2% |
| 2000 | 1.43 Billion USD | 12.04% |
| 1999 | 1.27 Billion USD | 38.2% |
| 1998 | 924.71 Million USD | 13.63% |
| 1997 | 813.82 Million USD | 28.25% |
| 1996 | 634.57 Million USD | 35.25% |
| 1995 | 469.2 Million USD | 24.17% |
| 1994 | 377.86 Million USD | 5.84% |
| 1993 | 357 Million USD | 14.72% |
| 1992 | 311.2 Million USD | 22.96% |
| 1991 | 253.1 Million USD | 59.68% |
| 1990 | 158.5 Million USD | 9.16% |
| 1989 | 145.2 Million USD | 79.48% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 26.56 Billion USD | -1.03% |
| 2024 Q2 | 26.8 Billion USD | 0.89% |
| 2024 Q3 | 28.31 Billion USD | 5.63% |
| 2023 Q3 | 28.19 Billion USD | 12.07% |
| 2023 Q2 | 25.15 Billion USD | 2.27% |
| 2023 FY | 26.84 Billion USD | 9.33% |
| 2023 Q1 | 24.59 Billion USD | 0.18% |
| 2023 Q4 | 26.84 Billion USD | -4.78% |
| 2022 Q1 | 23.61 Billion USD | -1.1% |
| 2022 FY | 24.55 Billion USD | 2.83% |
| 2022 Q4 | 24.55 Billion USD | -1.21% |
| 2022 Q3 | 24.85 Billion USD | -0.91% |
| 2022 Q2 | 25.08 Billion USD | 6.21% |
| 2021 FY | 23.87 Billion USD | -3.01% |
| 2021 Q1 | 23.85 Billion USD | -3.1% |
| 2021 Q4 | 23.87 Billion USD | 0.3% |
| 2021 Q3 | 23.8 Billion USD | -2.71% |
| 2021 Q2 | 24.47 Billion USD | 2.58% |
| 2020 Q2 | 25.51 Billion USD | -2.33% |
| 2020 Q4 | 24.61 Billion USD | -1.26% |
| 2020 Q3 | 24.93 Billion USD | -2.26% |
| 2020 FY | 24.61 Billion USD | -9.6% |
| 2020 Q1 | 26.11 Billion USD | -4.09% |
| 2019 Q4 | 27.23 Billion USD | -0.91% |
| 2019 Q3 | 27.48 Billion USD | 4.55% |
| 2019 Q1 | 26.44 Billion USD | 4.57% |
| 2019 Q2 | 26.28 Billion USD | -0.6% |
| 2019 FY | 27.23 Billion USD | 7.69% |
| 2018 FY | 25.28 Billion USD | 6.92% |
| 2018 Q2 | 23.95 Billion USD | -8.19% |
| 2018 Q3 | 25.49 Billion USD | 6.43% |
| 2018 Q4 | 25.28 Billion USD | -0.8% |
| 2018 Q1 | 26.09 Billion USD | 10.31% |
| 2017 Q4 | 23.65 Billion USD | 2.51% |
| 2017 Q2 | 21.75 Billion USD | 2.66% |
| 2017 Q1 | 21.19 Billion USD | -7.35% |
| 2017 FY | 23.65 Billion USD | 3.39% |
| 2017 Q3 | 23.07 Billion USD | 6.04% |
| 2016 Q1 | 20.67 Billion USD | 6.0% |
| 2016 Q2 | 21.51 Billion USD | 4.06% |
| 2016 Q3 | 22.1 Billion USD | 2.74% |
| 2016 FY | 22.87 Billion USD | 17.29% |
| 2016 Q4 | 22.87 Billion USD | 3.49% |
| 2015 Q2 | 16.75 Billion USD | 10.12% |
| 2015 Q3 | 20.72 Billion USD | 23.68% |
| 2015 Q1 | 15.21 Billion USD | 6.31% |
| 2015 Q4 | 19.5 Billion USD | -5.9% |
| 2015 FY | 19.5 Billion USD | 36.24% |
| 2014 Q2 | 12.91 Billion USD | 5.62% |
| 2014 Q3 | 13.7 Billion USD | 6.09% |
| 2014 Q1 | 12.23 Billion USD | 3.09% |
| 2014 FY | 14.31 Billion USD | 20.68% |
| 2014 Q4 | 14.31 Billion USD | 4.47% |
| 2013 Q3 | 11.25 Billion USD | 3.77% |
| 2013 FY | 11.86 Billion USD | 17.11% |
| 2013 Q4 | 11.86 Billion USD | 5.45% |
| 2013 Q2 | 10.84 Billion USD | 6.66% |
| 2013 Q1 | 10.16 Billion USD | 0.34% |
| 2012 Q4 | 10.13 Billion USD | 5.19% |
| 2012 FY | 10.13 Billion USD | 11.94% |
| 2012 Q1 | 9.11 Billion USD | 0.71% |
| 2012 Q2 | 9.16 Billion USD | 0.54% |
| 2012 Q3 | 9.63 Billion USD | 5.11% |
| 2011 Q1 | 8.29 Billion USD | 2.48% |
| 2011 Q3 | 8.8 Billion USD | 2.09% |
| 2011 FY | 9.04 Billion USD | 11.83% |
| 2011 Q4 | 9.04 Billion USD | 2.81% |
| 2011 Q2 | 8.62 Billion USD | 3.96% |
| 2010 Q1 | 8.21 Billion USD | -3.91% |
| 2010 FY | 8.09 Billion USD | -5.37% |
| 2010 Q4 | 8.09 Billion USD | 9.44% |
| 2010 Q3 | 7.39 Billion USD | -1.44% |
| 2010 Q2 | 7.5 Billion USD | -8.7% |
| 2009 Q3 | 9.02 Billion USD | 2.84% |
| 2009 Q4 | 8.55 Billion USD | -5.26% |
| 2009 FY | 8.55 Billion USD | 0.86% |
| 2009 Q1 | 8.57 Billion USD | 1.13% |
| 2009 Q2 | 8.77 Billion USD | 2.36% |
| 2008 Q1 | 8.17 Billion USD | -5.31% |
| 2008 Q4 | 8.47 Billion USD | -0.66% |
| 2008 Q3 | 8.53 Billion USD | 4.43% |
| 2008 FY | 8.47 Billion USD | -1.74% |
| 2008 Q2 | 8.17 Billion USD | 0.03% |
| 2007 FY | 8.62 Billion USD | 0.89% |
| 2007 Q1 | 8.7 Billion USD | 1.83% |
| 2007 Q2 | 8.93 Billion USD | 2.6% |
| 2007 Q3 | 7.81 Billion USD | -12.53% |
| 2007 Q4 | 8.62 Billion USD | 10.39% |
| 2006 Q1 | 8.52 Billion USD | 1.88% |
| 2006 Q2 | 8.34 Billion USD | -2.16% |
| 2006 Q3 | 8.18 Billion USD | -1.84% |
| 2006 FY | 8.55 Billion USD | 2.22% |
| 2006 Q4 | 8.55 Billion USD | 4.47% |
| 2005 Q4 | 8.36 Billion USD | 0.63% |
| 2005 Q1 | 9.06 Billion USD | -1.12% |
| 2005 Q2 | 8.26 Billion USD | -8.77% |
| 2005 Q3 | 8.31 Billion USD | 0.56% |
| 2005 FY | 8.36 Billion USD | -8.72% |
| 2004 FY | 9.16 Billion USD | -3.56% |
| 2004 Q3 | 9.02 Billion USD | -2.24% |
| 2004 Q1 | 9.51 Billion USD | 0.08% |
| 2004 Q2 | 9.22 Billion USD | -2.99% |
| 2004 Q4 | 9.16 Billion USD | 1.61% |
| 2003 Q3 | 2.15 Billion USD | 5.49% |
| 2003 Q2 | 2.03 Billion USD | 3.16% |
| 2003 FY | 9.5 Billion USD | 373.54% |
| 2003 Q4 | 9.5 Billion USD | 341.99% |
| 2003 Q1 | 1.97 Billion USD | -1.55% |
| 2002 FY | 2 Billion USD | 16.61% |
| 2002 Q3 | 1.88 Billion USD | 2.1% |
| 2002 Q2 | 1.84 Billion USD | 3.97% |
| 2002 Q1 | 1.77 Billion USD | 3.18% |
| 2002 Q4 | 2 Billion USD | 6.47% |
| 2001 Q3 | 1.64 Billion USD | 3.18% |
| 2001 Q2 | 1.59 Billion USD | 5.87% |
| 2001 Q1 | 1.5 Billion USD | 5.15% |
| 2001 FY | 1.72 Billion USD | 20.2% |
| 2001 Q4 | 1.72 Billion USD | 4.65% |
| 2000 Q4 | 1.43 Billion USD | 2.05% |
| 2000 FY | 1.43 Billion USD | 12.04% |
| 2000 Q1 | 1.28 Billion USD | 0.91% |
| 2000 Q3 | 1.4 Billion USD | 6.19% |
| 2000 Q2 | 1.32 Billion USD | 2.46% |
| 1999 FY | 1.27 Billion USD | 38.2% |
| 1999 Q3 | 1.14 Billion USD | 8.02% |
| 1999 Q4 | 1.27 Billion USD | 12.1% |
| 1999 Q2 | 1.05 Billion USD | 2.47% |
| 1999 Q1 | 1.03 Billion USD | 11.39% |
| 1998 Q1 | 823.8 Million USD | 1.23% |
| 1998 Q4 | 924.71 Million USD | 4.06% |
| 1998 Q3 | 888.6 Million USD | 6.6% |
| 1998 Q2 | 833.6 Million USD | 1.19% |
| 1998 FY | 924.71 Million USD | 13.63% |
| 1997 Q3 | 747.3 Million USD | 6.02% |
| 1997 Q1 | 684.2 Million USD | 7.82% |
| 1997 Q2 | 704.9 Million USD | 3.03% |
| 1997 Q4 | 813.82 Million USD | 8.9% |
| 1997 FY | 813.82 Million USD | 28.25% |
| 1996 Q4 | 634.57 Million USD | 8.03% |
| 1996 Q1 | 472 Million USD | 0.6% |
| 1996 Q2 | 489.7 Million USD | 3.75% |
| 1996 Q3 | 587.4 Million USD | 19.95% |
| 1996 FY | 634.57 Million USD | 35.25% |
| 1995 Q4 | 469.2 Million USD | 8.94% |
| 1995 Q3 | 430.7 Million USD | 6.5% |
| 1995 Q2 | 404.4 Million USD | 1.02% |
| 1995 FY | 469.2 Million USD | 24.17% |
| 1995 Q1 | 400.3 Million USD | 5.94% |
| 1994 Q4 | 377.86 Million USD | -0.38% |
| 1994 Q1 | 365 Million USD | 2.24% |
| 1994 Q2 | 374.8 Million USD | 2.68% |
| 1994 Q3 | 379.3 Million USD | 1.2% |
| 1994 FY | 377.86 Million USD | 5.84% |
| 1993 Q1 | 319.9 Million USD | 2.8% |
| 1993 Q2 | 340.5 Million USD | 6.44% |
| 1993 Q4 | 357 Million USD | 2.7% |
| 1993 Q3 | 347.6 Million USD | 2.09% |
| 1993 FY | 357 Million USD | 14.72% |
| 1992 Q4 | 311.2 Million USD | 13.87% |
| 1992 FY | 311.2 Million USD | 22.96% |
| 1992 Q2 | 255.4 Million USD | 1.43% |
| 1992 Q3 | 273.3 Million USD | 7.01% |
| 1992 Q1 | 251.8 Million USD | -0.51% |
| 1991 Q3 | 165.5 Million USD | 2.86% |
| 1991 FY | 253.1 Million USD | 59.68% |
| 1991 Q2 | 160.9 Million USD | 1.77% |
| 1991 Q4 | 253.1 Million USD | 52.93% |
| 1991 Q1 | 158.1 Million USD | -0.25% |
| 1990 Q4 | 158.5 Million USD | 3.59% |
| 1990 FY | 158.5 Million USD | 9.16% |
| 1990 Q2 | 148.6 Million USD | 1.99% |
| 1990 Q1 | 145.7 Million USD | 0.34% |
| 1990 Q3 | 153 Million USD | 2.96% |
| 1989 Q4 | 145.2 Million USD | 0.9% |
| 1989 Q3 | 143.9 Million USD | 0.0% |
| 1989 FY | 145.2 Million USD | 79.48% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| uniQure N.V. | 831.68 Million USD | -3127.745% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -2764.613% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -3351.021% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -16120.031% |
| bluebird bio, Inc. | 619.16 Million USD | -4235.674% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -21231.808% |
| Imunon, Inc. | 21.91 Million USD | -122377.943% |
| Editas Medicine, Inc. | 499.15 Million USD | -5278.07% |
| IQVIA Holdings Inc. | 26.68 Billion USD | -0.614% |
| Mettler-Toledo International Inc. | 3.35 Billion USD | -700.011% |
| Myriad Genetics, Inc. | 1.19 Billion USD | -2139.493% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | -725.638% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | -1805.269% |
| Verastem, Inc. | 149.71 Million USD | -17830.242% |
| Walgreens Boots Alliance, Inc. | 81.03 Billion USD | 66.873% |
| Waters Corporation | 4.62 Billion USD | -480.196% |
| Thermo Fisher Scientific Inc. | 98.72 Billion USD | 72.809% |
| Nektar Therapeutics | 398.03 Million USD | -6644.365% |
| Perrigo Company plc | 10.8 Billion USD | -148.354% |
| Dynavax Technologies Corporation | 997.09 Million USD | -2592.298% |
| Illumina, Inc. | 10.11 Billion USD | -165.501% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -94850.576% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -3340.093% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -11964.753% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -40765.885% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | -292.376% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -16138.084% |
| Evolus, Inc. | 188.99 Million USD | -14103.748% |
| Adicet Bio, Inc. | 207.29 Million USD | -12850.047% |
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -13498.845% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 18.849% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -12944.374% |
| FibroGen, Inc. | 423.52 Million USD | -6238.362% |
| Agilent Technologies, Inc. | 10.76 Billion USD | -149.417% |
| OPKO Health, Inc. | 2.01 Billion USD | -1234.435% |
| Homology Medicines, Inc. | 47.05 Million USD | -56947.411% |
| Geron Corporation | 394.07 Million USD | -6712.087% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -600.931% |
| Exelixis, Inc. | 2.94 Billion USD | -812.357% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -7185.082% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -17288.105% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -1963.434% |
| Zoetis Inc. | 14.28 Billion USD | -87.91% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -4463.611% |
| Abeona Therapeutics Inc. | 64 Million USD | -41843.69% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | -18.102% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -47880.84% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -797.798% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -722.306% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -4219.238% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -1448.795% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -2458.475% |
| Insmed Incorporated | 1.32 Billion USD | -1918.653% |
| TG Therapeutics, Inc. | 329.58 Million USD | -8044.981% |
| Incyte Corporation | 6.78 Billion USD | -295.818% |
| Emergent BioSolutions Inc. | 1.83 Billion USD | -1363.012% |